Review



inhibition curve (three parameters) analysis option  (GraphPad Software Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    GraphPad Software Inc inhibition curve (three parameters) analysis option
    (A) Initial screening of PLpro <t>inhibition</t> by 33 deubiquitinase inhibitors. (B) Initial screening of PLpro inhibition by 37 cysteine protease inhibitors. Reaction conditions: 20 nM PLpro, 50 μM Z-LRGG-AMC, 200 μM inhibitor, 20 mM Tris-HCl, 300 mM NaCl, pH 7.5.
    Inhibition Curve (Three Parameters) Analysis Option, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/inhibition curve (three parameters) analysis option/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    inhibition curve (three parameters) analysis option - by Bioz Stars, 2026-04
    90/100 stars

    Images

    1) Product Images from "Drug Repurposing for the SARS-CoV-2 Papain-Like Protease"

    Article Title: Drug Repurposing for the SARS-CoV-2 Papain-Like Protease

    Journal: bioRxiv

    doi: 10.1101/2021.06.04.447160

    (A) Initial screening of PLpro inhibition by 33 deubiquitinase inhibitors. (B) Initial screening of PLpro inhibition by 37 cysteine protease inhibitors. Reaction conditions: 20 nM PLpro, 50 μM Z-LRGG-AMC, 200 μM inhibitor, 20 mM Tris-HCl, 300 mM NaCl, pH 7.5.
    Figure Legend Snippet: (A) Initial screening of PLpro inhibition by 33 deubiquitinase inhibitors. (B) Initial screening of PLpro inhibition by 37 cysteine protease inhibitors. Reaction conditions: 20 nM PLpro, 50 μM Z-LRGG-AMC, 200 μM inhibitor, 20 mM Tris-HCl, 300 mM NaCl, pH 7.5.

    Techniques Used: Inhibition

    IC 50 characterizations for 16 small molecules on their inhibition of PLpro using 50 μM LRGG-AMC as a substrate. Experiments at different conditions were performed in triplicates.
    Figure Legend Snippet: IC 50 characterizations for 16 small molecules on their inhibition of PLpro using 50 μM LRGG-AMC as a substrate. Experiments at different conditions were performed in triplicates.

    Techniques Used: Inhibition

    IC 50 assays for 6 deubiquitinase inhibitors on their inhibition of 20 nM PLpro using 5 μM Ub-AMC as substrate. Experiments at different conditions were performed in triplicates.
    Figure Legend Snippet: IC 50 assays for 6 deubiquitinase inhibitors on their inhibition of 20 nM PLpro using 5 μM Ub-AMC as substrate. Experiments at different conditions were performed in triplicates.

    Techniques Used: Inhibition



    Similar Products

    90
    GraphPad Software Inc inhibition curve (three parameters) analysis option
    (A) Initial screening of PLpro <t>inhibition</t> by 33 deubiquitinase inhibitors. (B) Initial screening of PLpro inhibition by 37 cysteine protease inhibitors. Reaction conditions: 20 nM PLpro, 50 μM Z-LRGG-AMC, 200 μM inhibitor, 20 mM Tris-HCl, 300 mM NaCl, pH 7.5.
    Inhibition Curve (Three Parameters) Analysis Option, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/inhibition curve (three parameters) analysis option/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    inhibition curve (three parameters) analysis option - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A) Initial screening of PLpro inhibition by 33 deubiquitinase inhibitors. (B) Initial screening of PLpro inhibition by 37 cysteine protease inhibitors. Reaction conditions: 20 nM PLpro, 50 μM Z-LRGG-AMC, 200 μM inhibitor, 20 mM Tris-HCl, 300 mM NaCl, pH 7.5.

    Journal: bioRxiv

    Article Title: Drug Repurposing for the SARS-CoV-2 Papain-Like Protease

    doi: 10.1101/2021.06.04.447160

    Figure Lengend Snippet: (A) Initial screening of PLpro inhibition by 33 deubiquitinase inhibitors. (B) Initial screening of PLpro inhibition by 37 cysteine protease inhibitors. Reaction conditions: 20 nM PLpro, 50 μM Z-LRGG-AMC, 200 μM inhibitor, 20 mM Tris-HCl, 300 mM NaCl, pH 7.5.

    Article Snippet: The normalized PLPro activity against drug concentration was analyzed with the inhibition curve (three parameters) analysis option in GraphPad 8.0 to determine the IC 50 values.

    Techniques: Inhibition

    IC 50 characterizations for 16 small molecules on their inhibition of PLpro using 50 μM LRGG-AMC as a substrate. Experiments at different conditions were performed in triplicates.

    Journal: bioRxiv

    Article Title: Drug Repurposing for the SARS-CoV-2 Papain-Like Protease

    doi: 10.1101/2021.06.04.447160

    Figure Lengend Snippet: IC 50 characterizations for 16 small molecules on their inhibition of PLpro using 50 μM LRGG-AMC as a substrate. Experiments at different conditions were performed in triplicates.

    Article Snippet: The normalized PLPro activity against drug concentration was analyzed with the inhibition curve (three parameters) analysis option in GraphPad 8.0 to determine the IC 50 values.

    Techniques: Inhibition

    IC 50 assays for 6 deubiquitinase inhibitors on their inhibition of 20 nM PLpro using 5 μM Ub-AMC as substrate. Experiments at different conditions were performed in triplicates.

    Journal: bioRxiv

    Article Title: Drug Repurposing for the SARS-CoV-2 Papain-Like Protease

    doi: 10.1101/2021.06.04.447160

    Figure Lengend Snippet: IC 50 assays for 6 deubiquitinase inhibitors on their inhibition of 20 nM PLpro using 5 μM Ub-AMC as substrate. Experiments at different conditions were performed in triplicates.

    Article Snippet: The normalized PLPro activity against drug concentration was analyzed with the inhibition curve (three parameters) analysis option in GraphPad 8.0 to determine the IC 50 values.

    Techniques: Inhibition